DRTS
DRTS clinical trials: Alpha Tau Medical Ltd.
Every trial on ClinicalTrials.gov where Alpha Tau Medical Ltd. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 30
- Trials linked
- 29
- As lead sponsor
- 1
- As collaborator
- 8
- Primary completions as lead sponsor, next 90 days
DRTS on the catalyst calendar · DRTS registry changes
- Primary completion Dec 2026Sponsor estimateNo phase registeredNCT04002479Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic CancerAlpha Tau Medical LTD. · Pancreatic CancerActive, not recruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 1, 2026Sponsor estimateNo phase registeredNCT06910306Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent GlioblastomaAlpha Tau Medical LTD. · Recurrent GlioblastomaRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2026Sponsor estimateNo phase registeredNCT06698458Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic CancerAlpha Tau Medical LTD. · Pancreatic CancerActive, not recruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimateNo phase registeredNCT06615635Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised PatientsAlpha Tau Medical LTD. · Squamous Cell CarcinomaRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2027Sponsor estimateNo phase registeredNCT06755359Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic CancerAlpha Tau Medical LTD. · Pancreatic CancerRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2027Sponsor estimateNo phase registeredNCT06202248Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.Alpha Tau Medical LTD. · Non-metastatic Prostate CancerRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2027Sponsor estimateNo phase registeredNCT06026943Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic CancerAlpha Tau Medical LTD. · Pancreatic CancerRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2027Sponsor estimateNo phase registeredNCT05829291Alpha Radiation Emitters Device (DaRT) for the Treatment of Liver MetastasesAlpha Tau Medical LTD. · Liver MetastasesRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2027Sponsor estimateNo phase registeredNCT05781555Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant TumorsAlpha Tau Medical LTD. · Malignant TumorRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2026Sponsor estimateNo phase registeredNCT05657743Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (Feasibility and Safety)Alpha Tau Medical LTD. · Pancreatic CancerRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2027Sponsor estimateNo phase registeredNCT05632913Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung CancerAlpha Tau Medical LTD. · Recurrent Lung CancerRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2027Sponsor estimateNo phase registeredNCT05323253Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell CarcinomaAlpha Tau Medical LTD. · Recurrent Squamous Cell CarcinomaActive, not recruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 1, 2027Sponsor estimateNo phase registeredNCT04534127Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue NeoplasiaAlpha Tau Medical LTD. · Skin CancerRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2027Sponsor estimateNo phase registeredNCT04068155Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous TumorsAlpha Tau Medical LTD. · Skin CancerRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2028Sponsor estimateNo phase registeredNCT07290998Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate CancerAlpha Tau Medical LTD. · Prostate CancerNot yet recruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimateNo phase registeredNCT05047094Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCCAlpha Tau Medical LTD. · Head and Neck Squamous Cell CarcinomaRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimateNo phase registeredNCT03737734Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)Alpha Tau Medical LTD. · Skin CancerActive, not recruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 1, 2025ActualNo phase registeredNCT04543903Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate CancerAlpha Tau Medical LTD. · Prostate AdenocarcinomaCompletedDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2025ActualNo phase registeredNCT04540588Retreatment With Intratumoral Diffusing Alpha Radiation EmittersAlpha Tau Medical LTD. · Skin CancerCompletedDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2026Sponsor estimateNo phase registeredNCT03889899Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.Alpha Tau Medical LTD. · Skin CancerRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 13, 2024ActualNo phase registeredNCT03886181Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)Alpha Tau Medical LTD. · Skin CancerTerminatedDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2026Sponsor estimateNo phase registeredNCT06202118A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.Alpha Tau Medical LTD. · Breast CancerRecruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2025Sponsor estimateNo phase registeredNCT05065346Neoadjuvant DaRT for Locally Advanced Oral Cavity SCCAlpha Tau Medical LTD. · Squamous Cell CarcinomaUnknown statusDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2026Sponsor estimateNo phase registeredNCT06202339Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).Alpha Tau Medical LTD. · Carcinoma of the VulvaNot yet recruitingDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 30, 2023ActualNo phase registeredNCT03970967Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant MetastasesAlpha Tau Medical LTD. · Breast CarcinomaTerminatedDRTSLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 5 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner